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1. INTRODUCTION 
Streptozotocin, an antibiotic isolated from 
Streptomyces achromogenes [ 11, has diabetogenic 
[2], antitumoral [3] and oncogenic [4] activities. In 
our previous study on the diabetogenic action, we 
have shown that streptozotocin acts selectively on 
pancreatic islet cells to cause DNA strand breaks 
which stimulate poly(ADP-ribose) synthetase [S--8], 
a nuclear enzyme which has been suggested to par- 
ticipate in DNA repair [9,10]. 
The antitumoral action of streptozotocin is high- 
ly specific for insulinoma, and this agent has been 
successfully used for the treatment of human in- 
sulinomas [11,12]. In this paper, we present evi- 
dence that growth inhibition of hamster in- 
sulinoma cells due to streptozotocin is markedly 
enhanced by the poly(ADP-ribose) synthetase in- 
hibitors such as nicotinamide and 3-aminobenz- 
amide. Alkaline sucrose gradient analyses revealed 
that streptozotocin generates DNA strand breaks 
in the insulinoma cells, and that the inhibitor 
blocks the rejoining of DNA strand breaks. 
2. MATERIALS AND METHODS 
2.1. Materials 
Streptozotocin was purchased from Upjohn Co., 
Kalamazoo, Michigan; nicotinamide from Wako 
* To whom all correspondence should be addressed 
Abbreviations: RPM1 1640, Roswell Park Memorial ln- 
stitute Tissue Culture Medium 1640; EGTA ethylene 
glycol bis(/3-aminoethyl ether)N,N-tetraacetic acid 
Pure Chemical Industries, Tokyo; [3H]thymidine 
(6.7 Ci/mmol) from New England Nuclear, 
Boston; nicotinamide [U-t%]adenine dinucleotide 
([l%]NAD) (286 mCi/mmol) from Amersham In- 
ternational, Buckinghamshire; RPM1 1640 from 
Nissui Seiyaku, Tokyo; fetal bovine serum from 
Grand Island Biological Co., New York. 3-Amino- 
benzamide was kindly supplied by Dr. H. Nakano 
in Research Laboratories, Chugai Pharmaceutical 
Co., Tokyo. 
2.2. Cells and culture conditions 
In1 1 lR1 cells are a cultured insulinoma cell line 
established from BK-virus-induced islet cell tu- 
mors of Syrian golden hamsters [13,14]. The cells 
were maintained in a monolayer culture at 37°C in 
RPM1 1640 medium supplemented with 15% fetal 
bovine serum and 50 pg/ml kanamycin [ 141. 
2.3. Assay of islet nuclear poly(ADP-ribose) syn- 
thetase activity 
About 2000 islets were isolated from rat pan- 
creas by the method of Okamoto et al. [15]. Nu- 
clear fraction was prepared from islets and assayed 
for poly(ADP-ribose) synthetase activity as de- 
scribed previously [6,8,16]. 
2.4. Measurement of cell growth 
In1 11Rt cells in log phase were seeded at a den- 
sity of 5 x 104 cells/ml in culture tubes. After hav- 
ing been allowed to stand for 24 h to ensure at- 
tachment o the tubes, the cells were incubated in 
the presence or absence of streptozotocin with or 
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without poly(ADP-ribose) synthetase inhibitors for 
various time intervals, and counted in the medium 
containing 0.02% (w/v) erythrocin B on a hemo- 
cytometer to estimate the number of viable cells 
1171. 
2.5. Alkaline sucrose gradient analysis of DNA 
InlllRl cells were prelabelled for 20 h with 
1 &i/ml [3H]thymidine (1 iM total thymidine). 
The radioactivity was washed out, and the cells 
were incubated in fresh medium in the presence or 
absence of streptozotocin with or without nicotin- 
amide. After incubation, the cells were washed 
once with 0.9% cold NaCl, and 2 x 104 cells were 
then suspended in 50 ~1 of 0.9% NaCl and imme- 
diately layered over 0.5 ml of lysis solution (1 N 
NaOH, 0.01 M EDTA, 1% (v/v) Triton X-100) that 
had just been layered over 14.8 ml of a 5-20% 
(w/v) linear sucrose density gradient containing 
0.3 N NaOH, 0.7 M NaCl and 0.01 M EDTA 
[6-81. On the bottom of the gradient was 1 ml of 
an 80% (w/v) sucrose shelf. The loaded gradients 
were placed in the dark at 20°C for 30 min to al- 
low cell lysis, then centrifuged at 26 000 rev./min 
at 20°C for 3 h [6-81. After centrifugation, frac- 
tions of 33 drops were collected from the gradient. 
DNA in each fraction was precipitated by adding 
2 ml of 20% cold trichloroacetic acid with 200 pg 
bovine serum albumin as carrier [6-81. The pre- 
cipitate was collected on a Whatman GF/C filter, 
washed 3 times with 5% cold trichloroacetic acid, 
once with ethanol, and then counted for 3H-radio- 
activity in a toluene-based scintillation solution. 
3. RESULTS 
As shown in fig. 1, nicotinamide and 3-amino- 
benzamide inhibited poly(ADP-ribose) synthetase 
from rat pancreatic islets in a dose-dependent 
manner. The concentrations for 50% inhibition 
were estimated as follows; nicotinamide, 100 PM; 
3-aminobenzamide, 8 PM. The enzyme activity 
almost completely- inhibited by 10 mM nicotin- 
amide or 1 mM 3-aminobenzamide. Poly(ADP- 
ribose) synthetase activity has been found ubiq- 
uitously among eukaryotic cells, and the enzyme 
has been suggested to be identical among tissues or 
cells from various mammalian species [181. In fact, 
the enzyme from Chinese hamster ovary cells also 
was completely inhibited by 10 mM nicotinamide 
Concentration (M) 
Fig. 1. Inhibition of islet nuclear poly(ADP-ribose) syn- 
thetase. Poly(ADP-ribose) synthetase activity was deter- 
mined as described previously [6,8,16]. All activities 
were related to that of an equivalent quantity of islet nu- 
clear fraction without inhibitor (57.3 pmol poly(ADP- 
ribose) synthesized. 10 min-1 . pg islet nuclear DNA-‘). 
Nicotinamide (o), 3-aminobenzamide (0). 
or 1 mM 3-aminobenzamide [19]. Therefore, we 
employed these inhibitors of the rat islet enzyme 
throughout the present experiments with hamster 
insulinoma cells. 
We examined the effect of poly(ADP-ribose) 
synthetase inhibitors on streptozotocin-induced in- 
hibition of hamster insulinoma cell (In1 llR1) 
growth. As shown in fig.2, addition of 0.5 mg/ml 
streptozotocin inhibited In1 1 lR1 cell growth, but 
the cells regained their exponential growth rate 3- 
5 days after the addition. However, together with 
0.5 mg/ml streptozotocin and 10 mM nicotin- 
amide, the viable cell number was found to be pro- 
gressively decreased (fig.2a). 3-Aminobenzamide, 
the more potent inhibitor, enhanced the strep- 
tozotocin-induced inhibition of the insulinoma cell 
growth at the lower concentration (1 mM) (fig.2b). 
The poly(ADP-ribose) synthetase inhibitors per se 
had no effect on the growth of the cells at the con- 
centrations used. 
Streptozotocin has been shown in our previous 
study to cause DNA strand breaks in rat pancre- 
atic islet cells [6,7]. Recently it was reported that 
inhibitors of poly(ADP-ribose) synthetase such as 
?-aminobenzamide retard DNA repair from 
damages due to alkylating agents [10,20]. We 
therefore analyzed velocity sedimentation in an al- 
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Fig.2. Effect of poly(ADP-ribose) synthetase inhibitors 
on streptozotocin-induced inhibition of In 111 R 1 cell 
growth. The chemicals were added on 0 day, before 
which the cells had been seeded at a density of 5 X IO4 
cells/ml, and had been cultured for one day to ensure 
their attachment to culture tubes. Each point represents 
the viable cell number/ml, which was determined as de- 
scribed in Materials and Methods. (a) In 111 R 1 cells in- 
cubated without any addition (0); with 0.5 mg/ml strep- 
tozotocin (A); with 0.5 mg/ml streptozotocin and 10 mM 
nicotinamide (m); with 10 mM nicotinamide (0). (b) 
InlllRl cells incubated without any addition (0); with 
0.5 mg/ml streptozotocin (6); with 0.5 mg/ml strep- 
tozotocin and 1 mM 3-aminobenzamide (m); with 1 mM 
3-aminobenzamide (0). 
kaline sucrose gradient of DNA from In1 1 lR1 
cells treated with streptozotocin alone or with 
streptozotocin and nicotinamide. In1 1 lR1 cells 
were exposed to 0.5 mg/ml streptozotocin for 30 
min. Immediately after the treatment, the DNA 
sedimented slowly as a broad peak in the middle 
of the gradient, regardless of the presence or ab- 
sence of nicotinamide (fig.3a and b). As shown 
fig.3d, at 20 h after removal of streptozotocin the 
DNA was increased significantly in size to sedi- 
ment fast near the bottom of the gradient, the posi- 
tion at which undamaged DNA sediments. How- 
ever, when nicotinamide (10 mM) was present in 
the medium, the conversion of the low molecular 
weight DNA to a fast-sedimenting material was 
completely inhibited (fig.3c). 
Fraction Number 
Fig.3. Effect of nicotinamide on rejoining of strep- 
tozotocin-induced DNA strand breaks in In1 1 IR, cells. 
The cells, which had been labelled with i3H]thymidine, 
were treated with 0.5 mg/ml streptozotocin for 30 min 
in the presence or absence of 10 mM nicotinamide. 
Streptozotocin was then washed out, and the cells were 
further incubated for 20 h with or without 10 mM nic- 
otinamide. After incubation, DNA of the cells was ana- 
lyzed by velocity sedimentation in an alkaline sucrose 
density gradient as described in Materials and Methods. 
Each point represents % of total radioactivity recovered. 
The total radioactivity loaded onto the gradient was l-2 
x lo4 cpm; recovery was between 85 and 95%. (a) DNA 
of In1 1lRl cells incubated without any addition (*); 
with 0.5 mg/ml streptozotocin and 10 mM nicotinamide 
(0). (b) DNA of In 111 R 1 cells incubated without any ad- 
dition (a); with 0.5 mg/ml streptozotocin alone (A). (c) 
DNA of In1 1lRt cells incubated with 10 mM nic- 
otinamide for 20 h after removal of streptozotocin (0). 
(d) DNA of In1 1lRt cells incubated without nic- 
otinamide for 20 h after removal of streptozotocin (A). 
Sedimentation was from left to right. Arrow indicates 
the position of a bacteriophage ADNA 
(3.2 x 10’ molecular weight, New England BioLabs). 
4. DISCUSSION 
The present study has clearly demonstrated that 
nicotinamide and 3-aminobenzamide, islet poly- 
(ADP-ribose) synthetase inhibitors, markedly en- 
hance hamster insulinoma cell killing by strep- 
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tozotocin. This was supported by alternative 
evidence that the in vivo tumor-forming ability of 
the cells [14] is also completely abolished by a 
combined treatment with streptozotocin and nico- 
tinamide (unpublished data, Yamamoto, H. and 
Okamoto, H.). Alkaline sucrose gradient study has 
revealed that streptozotocin generates DNA strand 
breaks in the insulinoma cells, and that nicotin- 
amide inhibits the rejoining of the streptozotocin- 
induced strand breaks. Therefore, it is reasonable 
to assume that poly(ADP-ribose) synthetase inhib- 
itors inhibit repair of the DNA strand breaks and 
hence enhance streptozotocin-induced inhibition 
of the insulinoma cell growth, while in the absence 
of the inhibitors the cells regain their ability to 
grow as the DNA recovers from the streptozotocin- 
induced breaks. In mouse leukemia cells poly- 
(ADP-ribose) synthetase inhibitors were also ob- 
served to inhibit the rejoining step of DNA repair 
[ 10,201 although the inhibitors exhibited rather 
stimulatory effect on unscheduled DNA synthesis 
in normal cells such as rat hepatocytes 1211 and 
human lymphocytes [22,23]. 
Shall and his colleagues have reported that 
cytotoxicity of dimethylsulfate or methylnitro- 
sourea towards mouse leukemia cells was en- 
hanced by poly(ADP-ribose) synthetase inhibitors 
[ 10,241. Similar results were also observed in other 
rodent cell lines [25]. Caffeine may enhance X-ray- 
induced HeLa cell killing [26] or L-cell killing by 
alkylating agents [27] in a similar way, because caf- 
feine also has been shown to inhibit poly(ADP- 
ribose) synthetase [28]. The enhancement by poly- 
(ADP-ribose) synthetase inhibitors of cell killing 
effect of DNA damaging agents may have 
therapeutic potential in the treatment of human 
cancer. 
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